Searching for a cure, Improving lives

Our History

 The Beginnings

 Action Duchenne, initially called Parent Project UK, was set up in 2001 by Nick Catlin and Dr Janet Hoskin, when their son Saul was diagnosed with Duchenne Muscular Dystrophy.  The charity was the first organisation in the UK dedicated exclusively to Duchenne and Becker Muscular Dystrophy and, with the help and support of  friends and supporters and other Duchenne families,  developed into a national organisation.  

Giving Duchenne a Voice

 In 2003, the Right Honourable MP Kevin Brennan worked with Parent Project UK to set up the All Party Parliamentary Group on Muscular Dystrophy which has continued to be a powerful voice in the campaign for improved standards of care and promotion of research in Duchenne Muscular Dystrophy.  In addition, in this year Parent Project UK was involved in the setting up of the United Parent Project Muscular Dystrophy Group.  This sought to bring together various patient organisations from across the world to look for treatments and/or a potential cure for Duchenne.  In 2004, Parent Project UK mobilised a campaign of families and supporters to gain Government funding ultimately of over £4 million for the MDEX project on exon-skipping.  

Duchenne Conference 2003

Delegates at our first International Conference in 2003 at Imperial College London


Pushing the Frontiers of Research                                                                                                                

 In 2003, our first International Conference brought together researchers from across the world where we presented our first research grant to Imperial College London to fund an early exon-skipping project which has paved the way for the current exon-skipping clinical trials.  Since then Action Duchenne has funded more than 15 cutting edge research projects that aim to find treatments or a cure for Duchenne Muscular Dystrophy. You can read more about the projects we are currently funding here , and find information on everything we have supported in the past here .


Other Important Achievements

 In 2006 the DMD registry was set up by Action Duchenne.  This was the first patient registry for Duchenne in the UK and one of the first patient registries for Neuromuscular Disease in the World.  This has continued to be crucial in recruiting for clinical trials. In 2011 Action Duchenne became one of the first members of the Duchenne Alliance and will continue to fund research and support campaigns through this collaborative group of patient-led organisations. In 2011, Action Duchenne’s lottery-funded education project ‘Include Duchenne’ won the National Lottery Award for Education. This project worked with over 80 young people with Duchenne, their families and schools in order to improve reading skills through the Decipha Programme 


The Future

 Action Duchenne’s main aim has always been to find a cure for Duchenne and Becker through fundraising and campaigning to raise awareness and develop the necessary protocols.  However, there needs to be a dual strategy: searching for a cure whilst, at the same time, ensuring that everyone was gets the standard of care necessary to have the best life possible. This not only includes best medical care from qualified professionals in Centres of Excellence, but educational and social care so that young people with Duchenne and their families can look forward to a brighter future that involves good job or training prospects, independent living options and necessary support. Action Duchenne continues to fundraise, campaign and provide support and educational expertise to young people and families affected by Duchenne and we are grateful to all our fantastic families and supporters for making this work possible.


Support Action Duchenne with a monthly or one off donation



View our events

View All Events


Join the DMD registry for access to clinical trials


Action Duchenne launches new Research Strategy for Duchenne muscular dystrophy

November 17th, 2017

  Action Duchenne, a leading UK-wide patient and parent-led organisation for Duchenne Muscular Dystrophy, is

Tell me more

Long-term microdystrophin pre-clinical work, moving towards a potential therapy restores muscle function in canines

July 26th, 2017

Promising microdystrophin pre-clinical work, moving towards a potential therapy has shown to restore muscle function

Tell me more

FDA new approach would reduce number of patients treated with placebo

December 11th, 2017

The U.S. Food and Drug Administration (FDA) has published its recommendation for a new approach

Tell me more

Results announced from survey ‘Juggling care and daily life’

December 11th, 2017

The 17th October 2017 was an important date for the rare disease community.  The highlights of the

Tell me more

Duchenne – How do you measure a life?

Living with Duchenne – an animation

Taking charge of Duchenne

wordpress counter

Stay informed with regular updates from Action Duchenne